Comparative Analysis of MDA and Serum Minerals in Patients with Overt and Subclinical Hypothyroidism
- 1. PhD Scholar, Department of Biochemistry, Index Medical College Hospital & Research Centre, Indore (M.P.)
- 2. Head & Professor, Department of Biochemistry, Index Medical College Hospital & Research Centre, Indore (M.P.)
Description
Hypothyroidism is a prevalent thyroid gland disorder where the gland fails to meet the body’s demand for thyroid hormones, specifically triiodothyronine (T3) and thyroxine (T4). Hypothyroidism is categorized into overt (OH) and subclinical (SbH) forms. Overt hypothyroidism is characterized by elevated thyroid-stimulating hormone (TSH) levels and reduced T4 levels, whereas subclinical hypothyroidism presents with elevated TSH levels but normal T4 levels. The objective of this study is to assess the levels of malondialdehyde (MDA) and certain minerals—calcium, magnesium, and phosphorus—in patients diagnosed with SbH and OH. A total of 100 patients from index medical college Indore participated in the study, with half diagnosed with OH and the other half with SbH. The study also included 50 healthy controls of comparable age, and all three groups comprised 50% males and 50% females. Anthropometric examinations revealed significant (p<0.05) alterations in body mass index (BMI) and waist-to-hip ratio (WHpR) among the control, OH, and SbH groups. MDA levels were significantly elevated in hypothyroidism patients, with OH patients exhibiting the highest levels. SbH patients showed significantly (p<0.05) lower MDA levels compared to OH patients but significantly (p<0.05) higher levels compared to the control group. Levels of magnesium and phosphorus were significantly (p<0.05) elevated in OH patients compared to SbH patients and the control group, while the levels in SbH patients were not significantly different (p>0.05) from the control group. Conversely, serum calcium levels were significantly (p<0.05) reduced in OH patients compared to both SbH patients and controls, with no significant difference (p>0.05) between SbH patients and the control group. Additionally, MDA was found to be significantly (p<0.05). Correlated with WHpR in OH patients. Receiver Operating Characteristic (ROC) analysis demonstrated the utility of MDA in prognosing OH and SbH with excellent sensitivity. In conclusion, the increase in MDA levels due to lipid peroxidation may contribute to the progression of subclinical hypothyroidism to overt hypothyroidism.
Abstract (English)
Hypothyroidism is a prevalent thyroid gland disorder where the gland fails to meet the body’s demand for thyroid hormones, specifically triiodothyronine (T3) and thyroxine (T4). Hypothyroidism is categorized into overt (OH) and subclinical (SbH) forms. Overt hypothyroidism is characterized by elevated thyroid-stimulating hormone (TSH) levels and reduced T4 levels, whereas subclinical hypothyroidism presents with elevated TSH levels but normal T4 levels. The objective of this study is to assess the levels of malondialdehyde (MDA) and certain minerals—calcium, magnesium, and phosphorus—in patients diagnosed with SbH and OH. A total of 100 patients from index medical college Indore participated in the study, with half diagnosed with OH and the other half with SbH. The study also included 50 healthy controls of comparable age, and all three groups comprised 50% males and 50% females. Anthropometric examinations revealed significant (p<0.05) alterations in body mass index (BMI) and waist-to-hip ratio (WHpR) among the control, OH, and SbH groups. MDA levels were significantly elevated in hypothyroidism patients, with OH patients exhibiting the highest levels. SbH patients showed significantly (p<0.05) lower MDA levels compared to OH patients but significantly (p<0.05) higher levels compared to the control group. Levels of magnesium and phosphorus were significantly (p<0.05) elevated in OH patients compared to SbH patients and the control group, while the levels in SbH patients were not significantly different (p>0.05) from the control group. Conversely, serum calcium levels were significantly (p<0.05) reduced in OH patients compared to both SbH patients and controls, with no significant difference (p>0.05) between SbH patients and the control group. Additionally, MDA was found to be significantly (p<0.05). Correlated with WHpR in OH patients. Receiver Operating Characteristic (ROC) analysis demonstrated the utility of MDA in prognosing OH and SbH with excellent sensitivity. In conclusion, the increase in MDA levels due to lipid peroxidation may contribute to the progression of subclinical hypothyroidism to overt hypothyroidism.
Files
IJPCR,Vol16,Issue9,Article179.pdf
Files
(294.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:6402b8c4c7e5624adf4553bd580d8479
|
294.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-08-25
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue9,Article179.pdf
- Development Status
- Active
References
- 1. D. Y. Gaitonde, "Hypothyroidism: an update," South African Family Practice, vol. 54, no. 5, pp. 384-390, 2012. 2. B. Vaidya and S. H. Pearce, "Management of hypothyroidism in adults," BmJ, vol. 337, 20 08. 3. V. M. Darras, "Thyroid gland," in Sturkie's Avian Physiology: Elsevier, 2022, pp. 795-81 2. 4. M. Nilsson and H. Fagman, "Development of the thyroid gland," Development, vol. 144, no. 12, pp. 2123-2140, 2017. 5. P. R. Larsen and A. M. Zavacki, "Role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action," European thyroid journal, vol. 1, no. 4, pp. 232-242, 2012. 6. G. A. Brent, "Mechanisms of thyroid hormone action," The Journal of clinical investigation, vol. 122, no. 9, pp. 3035-3043, 2012. 7. P. Terranova, "Hypothyroidism☆," in Reference Module in Biomedical Sciences: Elsevier, 2017. 8. P. Terranova, "Hypothyroidism," in xPharm: The Comprehensive Pharmacology Reference, S. J. Enna and D. B. Bylund Eds. New York: Elsevier, 2007, pp. 1-3. 9. R. Ahmed, S. Al-Shaikh, and M. Akhtar, "Hashimoto thyroiditis: a century later," Advances in anatomic pathology, vol. 19, no. 3, pp. 181-186, 2012. 10. M. Imaizumi et al., "Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism," Thyroid, vol. 21, no. 11, pp. 1177-1182, 2011. 11. R. P. Peeters, "Subclinical hypothyroidism," New England Journal of Medicine, vol. 376, no. 26, pp. 2556-2565, 2017. 12. D. J. Betteridge, "What is oxidative stress?," Metabolism, vol. 49, no. 2, pp. 3 8, 2000. 13. J. N. Pearson-Smith and M. Patel, "Metabolic dysfunction and oxidative stress in epilepsy," International Journal of Molecular Sciences, vol. 18, no. 11, p. 2365, 2017. 14. K. M. Stepien et al., "Evidence of oxidative stress and secondary mitochondrial dysfunction in metabolic and non-metabolic disorders," Journal of clinical medicine, vol. 6, no. 7, p. 71, 2017. 15. N. L. Lugogo, D. Bappanad, and M. Kraft, "Obesity, metabolic dysregulation and oxidative stress in asthma," Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1810, no. 11, pp. 1120-1126, 2011. 16. Y. M. Taay and M. T. Mohammed, "Evaluation Of Serum Reactive Oxygen Species And Glutathione Peroxidase In Iraqi Obese/Obese-Hypertension Females," Plant Archives, vol. 20, no. 2, pp. 1165-1168, 2020. 17. M. T. Mohammed, S. M. Kadhim, A. N. Jassimand, and S. Abbas, "Free radicals and human health," International Journal of Innovation Sciences and Research, vol. 4, no. 6, pp. 218-223, 2015. 18. A. A. Refaie, A. Ramadan, N. M. Sabry, W. K. B. Khalil, and A.-T. H. Mossa, "Synthetic Insecticide Fipronil Induced Over Gene Expression, DNA and Liver Damage in Female Rats: The Protective Role of Fish Oil," Egyptian Journal of Chemistry, vol. 64, no. 5, 10.21608/ ejchem.2021.58506.3264. pp. 2325-2336,20 21, doi: 19. L.-J. Su et al., "Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis," Oxidative medicine and cellular longevity, vol. 2019, 2019. 20. R. Vona, L. Gambardella, C. Cittadini, E. Straface, and D. Pietraforte, "Biomarkers of oxidative stress in metabolic syndrome and associated diseases," Oxidative medicine and cellular longevity, vol. 2019, 2019. 21. N. Sharaf et al., "Antioxidants as a Potential Therapy for Reduction of Oxidative Stress in Autistic Children," Egyptian Journal of Chemistry, pp. -, 2021, doi: 10.21608/ejchem. 2021. 104004.4812. 22. S. M. T. Gharibzahedi and S. M. Jafari, "The importance of minerals in human nutrition: Bioavailability, food fortification, processing effects and nanoencapsulation," Trends in Food Science & Technology, vol. 62, pp. 119 132,2017/04/01/2017, doi: https://doi.org/10.1016 /j.tifs.2017.02.017. 23. M. N. Amin et al., "Effect of lipid peroxidation, antioxidants, macro minerals and trace elements on eczema," Archives of Dermatological Research, vol. 307, no. 7, pp. 617-623, 2015/09/01 2015, doi: 10.1007/s00403-015-15 70 2. 24. M. R. Islam et al., "Alterations of serum macrominerals and trace elements are associated with major depressive disorder: a case-control study," BMC psychiatry, vol. 18, no. 1, pp. 1-7 , 2018. 25. M. I. Chowdhury et al., "Elevated serum MDA and depleted non-enzymatic antioxidants, macro-minerals and trace elements are associated with bipolar disorder," Journal of Trace Elements in Medicine and Biology, vol. 39, pp. 16 2-168, 2017. 26. T. F. Noshin, M. R. Ali, and S. Banik, "Increased oxidative stress and altered serum macro-minerals and trace elements levels are associated with coronary artery disease," Journal of Trace Elements in Medicine and Biology, vol. 64, p. 126707, 2021. 27. J. Benge and S. Aust, "Estimation of serum Malondialdehyde level in hoffee PA. and Jones ME," Methods in Enzymology Hoffee Jones. Academic Press, New York, San Francisco, London, ASubsidinary of Harcoart Brace Jovanovich, Publisher, vol. 51, p. 302, 1978. 28. V. Fatourechi, "Subclinical hypothyroidism: an update for primary care physicians," (in eng), Mayo Clin Proc, vol. 84, no. 1, pp. 65-71, 20 09, doi: 10.1016/S0025-6196(11)60809-4. 29. B. Biondi, A. R. Cappola, and D. S. Cooper, "Subclinical Hypothyroidism: A Review," (in eng), Jama, vol. 322, no. 2, pp. 153-160, Jul 9 2019, doi: 10.1001/jama.2019.9052. 30. K. Walczak and L. Sieminska, "Obesity and Thyroid Axis," International Journal of Environmental Research and Public Health, vol. 18, no. 18, p. 9434, 2021. 31. Abbas HA, Alsaade KA, AlMAshhdan HA. Study the effect of cyperus rotundus extracted as mouthwash on the corrosion of dental amalgam. InIOP Conference Series: Materials Science and Engineering 2019 Jul 1 (Vol. 571, No. 1, p. 012074). IOP Publishing. 32. Y. Taay, M. Mohammed, R. Abbas, A. Ayad, and M. Mahdi, "Determination of some biochemical parameters in sera of normotensive and hypertensive obese female in Baghdad," in Journal of Physics: Conference Series, 2021, vol. 1853, no. 1: IOP Publishing, p. 012037. 33. A. Sadiq and A. Jassim, "Evaluation of serum ferritin and hepcidin level and their association with obesity in Iraqi obese women," in Journal of Physics: Conference Series, 2021, vol. 1853, no. 1: IOP Publishing, p. 012026. 34. A. Verma, M. Jayaraman, H. K. Kumar, and K. D. Modi, "Hypothyroidism and obesity," Saudi Med J, vol. 29, no. 8, pp. 1135-1138, 20 08. 35. D. Sanyal and M. Raychaudhuri, "Hypothyroidism and obesity: An intriguing link," (in eng), Indian J Endocrinol Metab, vol. 20, no. 4, pp. 554-557, Jul Aug 2016, doi: 10.4103/ 22 30- 8210.183454. 36. A. N. Torun, S. Kulaksizoglu, M. Kulaksizoglu, B. O. Pamuk, E. Isbilen, and N. B. Tutuncu, "Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism," Clinical endocrinology, vol. 70, no. 3, pp. 469-474, 2009. 37. B. Joshi, S. Singh, A. Saini, S. Gupta, and B. Vanishree, "A study of lipid peroxidation and total antioxidant capacity in hyperthyroid & hypothyroid female subjects," Galore Int J Health Sci Res, vol. 3, no. 4, pp. 1-8, 2018. 38. B. Tejovathi et al., "Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism," Experimental and Clinical Endocrinology & Diabetes, vol. 121, no. 05, pp. 306-309, 2013. 39. A. Haribabu et al., "Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism," Endocrine, vol. 44, no. 1, pp. 152-157, 2013/08/01 2013, doi: 10. 1007/s12020-012-9849-y. 40. M. Naoi, W. Maruyama, M. Shamoto-Nagai, H. Yi, Y. Akao, and M. Tanaka, "Oxidative stress in mitochondria," Molecular neurobiology, vol. 31, no. 1, pp. 81-93, 2005. 41. G. Siciliano et al., "Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy," Molecular Medicine, vol. 8, no. 6, pp. 326-333, 2002. 42. M. L. Gheorghiu and C. Badiu, "Selenium involvement in mitochondrial function in thyroid disorders," Hormones, vol. 19, no. 1, pp. 25-30, 2020. 43. S. SUGIYAMA, T. KATO, T. OZAWA, and K. YAGI, "Deterioration of mitochondrial function in heart muscles of rats with hypothyroidism,"Journal of Clinical Biochemistry and Nutrition, vol. 11, no. 3, pp. 199-204, 1991. 44. F. Monzani, N. Caraccio, G. Siciliano, L. Manca, L. Murri, and E. Ferrannini, "Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism," The Journal of Clinical Endocrinology & Metabolism, vol.82, no. 10, pp. 3315-3318, 1997. 45. J.Kvetny,L.Wilms,P.Pedersen,andJ.Larsen,"Subclinicalhypothyroidism affects mitochondrial function," Hormone and Metabolic Research, vol. 42, no. 05, pp. 324- 327, 2010.46. S. Yilmaz, S. Ozan, F. Benzer, and H. Canatan, "Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism," Cell Biochemistry and Function: Cellular biochemistry and its modulation by active agents or disease, vol. 21, no. 4, pp. 325-330, 2003. 47. H. Erdamar et al., "The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status," Clinical chemistryandlaboratorymedicine,vol.46,no.7,pp.1004-1010,2008. 48. Al-Mashhadani HA, Alshujery MK, Khazaal FA, Salman AM, Kadhim MM,Abbas ZM, Farag SK, Hussien HF. Anti-corrosive substance as green inhibitor for carbon steel in saline and acidic media. InJournal of Physics: Conference Series 2021 Mar 1 (Vol. 1818, No. 1, p. 012128). IOP Publishing. 49. V.Reddyetal.,"Antioxidantdefenseinovertandsubclinicalhypothyroidism,"Hormon eandMetabolicResearch,vol.45,no.10,pp.754- 758, 2013. 50. H. K. Vincent, K. E. Innes, and K. R. Vincent, "Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity," Diabetes, obesity and metabolism, vol. 9, no. 6, pp. 813-839, 2007. 51. Suryasa, I. W., Rodríguez-Gámez, M., &Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938 52. W. H. Albuali, "Evaluation of oxidant-antioxidant status in overweight and morbidly obese Saudi children," World journal of clinical pediatrics, vol. 3,no. 1, p. 6, 2014.